← Leaderboards
K. Sreekumaran Nair
University Of Vermont &St Agric College
$38,267,634
Attributed
$42,705,836
Total exposure
35
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$57,664,072 · 37
By mechanism
U24$26,684,811 · 6
R01$20,472,112 · 3
P01$6,223,693 · 2
M01$1,720,541 · 22
R33$1,325,679 · 1
R21$1,078,236 · 2
Top collaborators
- Ian R Lanza9 shared
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchProtein BiosynthesisBaseHuman SubjectInsulinResponseMetabolicFundingIn VivoProteinsExerciseMuscle ProteinsProtein MetabolismProgramsMitochondriaMuscleMeasurementResearch PersonnelClinicLabelStable IsotopeUnited States National Institutes Of HealthMetabolomicsProtein Degradation
Grant awards (143)
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People$663,228
R01 · FY2025 · AG · contact PI
Mayo Clinic Physical Activity Research Center: Metabolomics and Proteomics Analysis Site$416,600
U24 · FY2025 · DK · contact PI
Mayo Clinic Physical Activity Research Center: Metabolomics and Proteomics Analysis Site$790,900
U24 · FY2024 · DK · contact PI
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People$675,213
R01 · FY2024 · AG · contact PI
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People$602,339
R01 · FY2023 · AG · contact PI
Mayo Clinic Physical Activity Research Center: Metabolomics and Proteomics Analysis Site$1,519,992
U24 · FY2022 · DK · contact PI
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People$602,339
R01 · FY2022 · AG · contact PI
Mayo Clinic Physical Activity Research Center: Metabolomics and Proteomics Analysis Site$1,792,177
U24 · FY2021 · DK · contact PI
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People$602,339
R01 · FY2021 · AG · contact PI
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People$67,218
R01 · FY2021 · AG · contact PI
Metformin Effect on Brain Function in Insulin Resistant Elderly People$49,973
R21 · FY2021 · AG · contact PI
Mayo Clinic Physical Activity Research Center: Metabolomics and Proteomics Analysis Site$1,890,560
U24 · FY2020 · DK · contact PI
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People$602,339
R01 · FY2020 · AG · contact PI
Mayo Clinic Physical Activity Research Center: Metabolomics and Proteomics Analysis Site$1,296,476
U24 · FY2019 · DK · contact PI
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People$648,182
R01 · FY2019 · AG · contact PI
Metformin Effect on Brain Function in Insulin Resistant Elderly People$235,918
R21 · FY2019 · AG · contact PI
Mayo Clinic Physical Activity Research Center: Metabolomics and Proteomics Analysis Site$988,560
U24 · FY2018 · DK · contact PI
Metformin Effect on Brain Function in Insulin Resistant Elderly People$196,168
R21 · FY2018 · AG · contact PI
Mayo Clinic Metabolomics Resource Core$1,431,355
U24 · FY2017 · DK · contact PI
ADMINISTRATIVE CORE$497,478
U24 · FY2017 · DK · contact PI
PROMOTION AND OUTREACH$418,129
U24 · FY2017 · DK · contact PI
TECHNOLOGY MASS SPECTROMETRY$261,447
U24 · FY2017 · DK · contact PI
TECHNOLOGY NMR SPECTROSCOPY$254,301
U24 · FY2017 · DK · contact PI
Mayo Clinic Physical Activity Research Center: Metabolomics and Proteomics Analysis Site$96,116
U24 · FY2017 · DK · contact PI
Mayo Clinic Physical Activity Research Center: Metabolomics and Proteomics Analysis Site$85,024
U24 · FY2017 · DK · contact PI
Mayo Clinic Metabolomics Resource Core$1,550,929
U24 · FY2016 · DK · contact PI
ADMINISTRATIVE CORE$529,231
U24 · FY2016 · DK · contact PI
PROMOTION AND OUTREACH$418,129
U24 · FY2016 · DK · contact PI
TECHNOLOGY MASS SPECTROMETRY$326,235
U24 · FY2016 · DK · contact PI
TECHNOLOGY NMR SPECTROSCOPY$277,334
U24 · FY2016 · DK · contact PI
Mayo Clinic Metabolomics Resource Core$1,927,204
U24 · FY2015 · DK · contact PI
TECHNOLOGY MASS SPECTROMETRY$579,304
U24 · FY2015 · DK · contact PI
ADMINISTRATIVE CORE$557,091
U24 · FY2015 · DK · contact PI
PROMOTION AND OUTREACH$434,029
U24 · FY2015 · DK · contact PI
TECHNOLOGY NMR SPECTROSCOPY$356,780
U24 · FY2015 · DK · contact PI
In Vivo Regulation of Protein Turnover by Hormones$159,000
R56 · FY2015 · DK · contact PI
Mayo Clinic Metabolomics Resource Core$78,694
U24 · FY2015 · DK · contact PI
Mayo Clinic Metabolomics Resource Core$2,017,609
U24 · FY2014 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$682,432
R01 · FY2014 · AG · contact PI
ADMINISTRATIVE CORE$594,804
U24 · FY2014 · DK · contact PI
TECHNOLOGY MASS SPECTROMETRY$590,434
U24 · FY2014 · DK · contact PI
In Vivo Regulation of Protein Turnover by Hormones$588,090
R01 · FY2014 · DK · contact PI
TECHNOLOGY NMR SPECTROSCOPY$498,576
U24 · FY2014 · DK · contact PI
PROMOTION AND OUTREACH$333,795
U24 · FY2014 · DK · contact PI
Mayo Clinic Metabolomics Resource Core$39,114
U24 · FY2014 · DK · contact PI
Mayo Clinic Metabolomics Resource Core$1,918,202
U24 · FY2013 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$648,582
R01 · FY2013 · AG · contact PI
In Vivo Regulation of Protein Turnover by Hormones$568,986
R01 · FY2013 · DK · contact PI
ADMINISTRATIVE CORE$558,995
U24 · FY2013 · DK · contact PI
TECHNOLOGY NMR SPECTROSCOPY$541,508
U24 · FY2013 · DK · contact PI
TECHNOLOGY MASS SPECTROMETRY$483,904
U24 · FY2013 · DK · contact PI
PROMOTION AND OUTREACH$333,795
U24 · FY2013 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$690,347
R01 · FY2012 · AG · contact PI
In Vivo Regulation of Protein Turnover by Hormones$591,176
R01 · FY2012 · DK · contact PI
In Vivo Regulation of Protein Turnover by Hormones$143,711
R01 · FY2012 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$694,484
R01 · FY2011 · AG · contact PI
In Vivo Regulation of Protein Turnover by Hormones$592,740
R01 · FY2011 · DK · contact PI
In Vivo Regulation of Protein Turnover by Hormones$729,504
R01 · FY2010 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$705,805
R01 · FY2010 · AG · contact PI
In Vivo Regulation of Protein Turnover by Hormones$32,997
R01 · FY2010 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$747,665
R01 · FY2009 · AG · contact PI
In Vivo Regulation of Protein Turnover by Hormones$455,973
R01 · FY2009 · DK · contact PI
Plasma protein synthesis and abundance in T1 diabetes$663,986
R33 · FY2008 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$576,867
R01 · FY2008 · AG · contact PI
In Vivo Regulation of Protein Turnover by Hormones$443,146
R01 · FY2008 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$151,100
R01 · FY2008 · AG · contact PI
Plasma protein synthesis and abundance in T1 diabetes$661,693
R33 · FY2007 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$569,313
R01 · FY2007 · AG · contact PI
In Vivo Regulation of Protein Turnover by Hormones$439,481
R01 · FY2007 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$567,177
R01 · FY2006 · AG · contact PI
In Vivo Regulation of Protein Turnover by Hormones$439,903
R01 · FY2006 · DK · contact PI
Mechanism of Muscle Wasting in Aging Man$584,386
R01 · FY2005 · AG
In Vivo Regulation of Protein Turnover by Hormones$437,857
R01 · FY2005 · DK
Plasma protein synthesis and abundance in T1 diabetes$301,177
R21 · FY2005 · DK
EFFECTS OF ORAL PROTEIN SUPPLEMENTATION ON SKELETAL MUSCLE PROTEIN SYNTHESIS$156,146
M01 · FY2005 · RR
PATHOGENESIS OF SARCOPENIA AND METABOLIC CHANGE IN AGING$47,389
M01 · FY2005 · RR
INTERACTION BETWEEN AGE AND OBESITY ON SKELETAL MUSCLE MITOCHONDRIAL CAPACITY$42,413
M01 · FY2005 · RR
DOES DHEA ENHANCE THE EFFECTS OF EXERCISE IN POSTMENOPAUSAL WOMEN?$38,148
M01 · FY2005 · RR
REDUCED SKELETAL MUSCLE OXIDATIVE ENERGY METABOLISM$11,847
M01 · FY2005 · RR
MOLECULAR GENETICS OF TYPE 2 DIABETES IN ASIAN INDIANS$6,161
M01 · FY2005 · RR
EFFECTS OF INSULIN DEPRIVATION AND REINTRODUCTION ON MITOCHONDRIAL PROTEIN DYNAM$4,739
M01 · FY2005 · RR
MECHANISMS OF MUSCLE WASTING IN AGING - ROLE OF ENDURANCE EXERCISE$2,132
M01 · FY2005 · RR
Pathogenesis of Sarcopenia and Metabolic Change in Aging$811,300
M01 · FY2004 · RR
IN VIVO REGULATION OF PROTEIN TURNOVER BY HORMONES$348,903
R01 · FY2004 · DK
PATHOGENESIS OF SARCOPENIA AND METABOLIC CHANGE IN AGING$330,886
P01 · FY2004 · AG
Plasma protein synthesis and abundance in T1 diabetes$295,000
R21 · FY2004 · DK
DHEA effect on mood of adrenalectomised/hypoadrenal pts$112,627
M01 · FY2004 · RR
Does DHEA Enhance Effects of Exercise in Postmenopause?$101,504
M01 · FY2004 · RR
Muscle Wasting in Aging--Role of Endurance Exercise$85,745
M01 · FY2004 · RR
The effects of prednisone on muscle protein synthesis and breakdown$36,383
M01 · FY2004 · RR
Oral Protein Supplement &Skeletal Muscle Protein Synthe$15,295
M01 · FY2004 · RR
Myosin heavy chain &cytochrome oxidase mRNA expression$14,831
M01 · FY2004 · RR
Insulin Deprivation/infusion &Mitochondrial Protein$12,978
M01 · FY2004 · RR
Skeletal Muscle Oxidative Energy Metabolism &NIDDM$464
M01 · FY2004 · RR
MECHANISM OF MUSCLE WASTING IN AGING MAN$562,353
R01 · FY2003 · AG
IN VIVO REGULATION OF PROTEIN TURNOVER BY HORMONES$349,063
R01 · FY2003 · DK
PATHOGENESIS OF SARCOPENIA AND METABOLIC CHANGE IN AGING$1,803,006
P01 · FY2002 · AG
MECHANISM OF MUSCLE WASTING IN AGING MAN$548,883
R01 · FY2002 · AG
IN VIVO REGULATION OF PROTEIN TURNOVER BY HORMONES$352,750
R01 · FY2002 · DK
Pathogenesis of Sacropenia and Metabolic Change in Aging$325,125
P01 · FY2002 · AG
CORE--BIOMEDICAL MASS SPECTROMETRY$0
P01 · FY2002 · AG
CORE--BIOMEDICAL MASS SPECTROMETRY$0
P01 · FY2002 · AG
PREDNISONE AND MUSCLE PROTEIN SYNTHESIS AND BREAKDOWN: ARTERIOVENOUS STUDIES$0
M01 · FY2002 · RR
EFFECTS OF FREE FATTY ACIDS ON SPLANCHNIC GLUCOSE UPTAKE$0
M01 · FY2002 · RR
INSULIN AND PROTEIN DYNAMICS IN PERIPHERAL &SPLANCHNIC$0
M01 · FY2002 · RR
NITRIC OXIDE KINETICS ACROSS SKELETAL MUSCLE IN TYPE 1 DIABETES MELLITUS$0
M01 · FY2002 · RR
MYOSIN &MITOCHONDRIAL PROTEIN SYNTHESIS IN PEOPLE W/ TYPE II DIABETES$0
M01 · FY2002 · RR
MEASUREMENT OF MUSCLE PROTEIN SYNTHESIS &BREAKDOWN$0
M01 · FY2002 · RR
INSULIN DEPRIVATION ON REGIONAL SUBSTRATE METABOLISM IN KIDNEY$0
M01 · FY2002 · RR
SHORT-TERM TESTOSTERONE REPLACEMENT IN ELDERLY MEN--PILOT STUDY$0
M01 · FY2002 · RR
IN VIVO REGULATION OF PROTEIN TURNOVER BY HORMONES$0
M01 · FY2002 · RR
EFFECTS OF ENDURANCE TRAINING ON MUSCLE PROTEIN SYNTHESIS IN WOMEN AND MEN$0
M01 · FY2002 · RR
PATHOGENESIS OF SARCOPENIA AND METABOLIC CHANGE IN AGING$1,787,727
P01 · FY2001 · AG
MECHANISM OF MUSCLE WASTING IN AGING MAN$535,799
R01 · FY2001 · AG
IN VIVO REGULATION OF PROTEIN TURNOVER BY HORMONES$352,750
R01 · FY2001 · DK
EFFECTS OF FREE FATTY ACIDS ON SPLANCHNIC GLUCOSE UPTAKE$0
M01 · FY2001 · RR
INSULIN AND PROTEIN DYNAMICS IN PERIPHERAL &SPLANCHNIC$0
M01 · FY2001 · RR
NITRIC OXIDE KINETICS ACROSS SKELETAL MUSCLE IN TYPE 1 DIABETES MELLITUS$0
M01 · FY2001 · RR
MYOSIN &MITOCHONDRIAL PROTEIN SYNTHESIS IN PEOPLE W/ TYPE II DIABETES$0
M01 · FY2001 · RR
MEASUREMENT OF MUSCLE PROTEIN SYNTHESIS &BREAKDOWN$0
M01 · FY2001 · RR
INSULIN DEPRIVATION ON REGIONAL SUBSTRATE METABOLISM IN KIDNEY$0
M01 · FY2001 · RR
SHORT-TERM TESTOSTERONE REPLACEMENT IN ELDERLY MEN--PILOT STUDY$0
M01 · FY2001 · RR
EFFECTS OF ENDURANCE TRAINING ON MUSCLE PROTEIN SYNTHESIS IN WOMEN AND MEN$0
M01 · FY2001 · RR
IN VIVO REGULATION OF PROTEIN TURNOVER BY HORMONES$0
M01 · FY2001 · RR
CORE--BIOMEDICAL MASS SPECTROMETRY$0
P01 · FY2001 · AG
PREDNISONE AND MUSCLE PROTEIN SYNTHESIS AND BREAKDOWN: ARTERIOVENOUS STUDIES$0
M01 · FY2001 · RR
PATHOGENESIS OF SARCOPENIA AND METABOLIC CHANGE IN AGING$1,748,385
P01 · FY2000 · AG
MECHANISM OF MUSCLE WASTING IN AGING MAN$488,667
R01 · FY2000 · AG
IN VIVO REGULATION OF PROTEIN TURNOVER BY HORMONES$352,750
R01 · FY2000 · DK
CORE--BIOMEDICAL MASS SPECTROMETRY$228,564
P01 · FY2000 · AG
DIETARY THERAPY OF ADRENOMYELONEUROPATHY$187,536
M01 · FY2000 · RR
IN VIVO REGULATION OF PROTEIN TURNOVER BY HORMONES$35,275
R01 · FY2000 · DK
DIETARY THERAPY OF ADRENOMYELONEUROPATHY$32,903
M01 · FY2000 · RR
PREDNISONE AND MUSCLE PROTEIN SYNTHESIS AND BREAKDOWN: ARTERIOVENOUS STUDIES$0
M01 · FY2000 · RR
EFFECTS OF FREE FATTY ACIDS ON SPLANCHNIC GLUCOSE UPTAKE$0
M01 · FY2000 · RR
INSULIN AND PROTEIN DYNAMICS IN PERIPHERAL &SPLANCHNIC$0
M01 · FY2000 · RR
NITRIC OXIDE KINETICS ACROSS SKELETAL MUSCLE IN TYPE 1 DIABETES MELLITUS$0
M01 · FY2000 · RR
MYOSIN &MITOCHONDRIAL PROTEIN SYNTHESIS IN PEOPLE W/ TYPE II DIABETES$0
M01 · FY2000 · RR
MEASUREMENT OF MUSCLE PROTEIN SYNTHESIS &BREAKDOWN$0
M01 · FY2000 · RR
INSULIN DEPRIVATION ON REGIONAL SUBSTRATE METABOLISM IN KIDNEY$0
M01 · FY2000 · RR
SHORT-TERM TESTOSTERONE REPLACEMENT IN ELDERLY MEN--PILOT STUDY$0
M01 · FY2000 · RR
IN VIVO REGULATION OF PROTEIN TURNOVER BY HORMONES$0
M01 · FY2000 · RR
EFFECTS OF ENDURANCE TRAINING ON MUSCLE PROTEIN SYNTHESIS IN WOMEN AND MEN$0
M01 · FY2000 · RR